🔗 Visit the ClinicalTrials.gov page for NCT00546780
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. | Proc Natl Acad Sci U S A | 2008 | 1.28 |
| 2 | Bortezomib combination therapy in multiple myeloma. | Semin Hematol | 2012 | 1.01 |
| 3 | Experimental approaches in the treatment of multiple myeloma. | Ther Adv Hematol | 2011 | 0.76 |